MedPath

Psychological Vulnerabilities and Transgender Adolescents: A Descriptive Epidemiology Study

Completed
Conditions
Gender Dysphoria, Adolescent
Registration Number
NCT05126134
Lead Sponsor
University Hospital, Toulouse
Brief Summary

The number of adolescents engaging in a transidentity journey has been increasing rapidly over the last decade. However, the knowledge of the medical world concerning the specificities of these adolescents is still too little in France. The objective of this study is to refine the knowledge of the different health care providers who are brought to meet these adolescents. This research proposes to study more specifically the register of psychological vulnerabilities: to cite only a few examplesThese include disorders such as depression, anxiety disorders and eating disorders, all of which cause suffering and difficulties in everyday life. A better understanding of the presence or absence and the distribution of these different types of vulnerabilities among transgender adolescents would allow, among other things, to promote their their screening by health care providers. This better screening would allow doctors to physicians to offer targeted treatment for these disorders in parallel with the transition process. transition process.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Be between 12 and 18 years old
  • Be followed up at the gender consultation of the Toulouse University Hospital
Exclusion Criteria
  • Have not yet completed the first consultation on gender issues at the time of selection.
  • Have only one last appointment with the gender consultation at the time of selection

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
list of diagnoses of mental disordersenrollment

description of the prevalence of psychiatric comorbidities present in adolescents receiving follow-up in a specialized consultation on gender dysphoria using Diagnostic and Statistical Manual of Mental Disorders 5

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chu Toulouse

🇫🇷

Toulouse, France

Chu Toulouse
🇫🇷Toulouse, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.